AMCP strongly supports the passage of the MVP Act. Medicaid beneficiaries are among America's most vulnerable patients. Value-based payment arrangements are a critical tool for promoting patient access to high-quality, affordable care.
JMCP Findings - Stakeholder Insights on Cost, Quality, and Patient Voice in Managed Care for Wet AMDd
FINDINGS FROM THE AMCP MARKET INSIGHTS PROGRAM | October, 2024
Summary
Wet age-related macular degeneration is a condition that can lead to significant vision loss. It is treated with regular injections, which often work well at preventing vision loss but are a burden to patients with the condition. Health care organizations can help by better understanding this burden and doing what they can to lessen it. Importantly, this includes talking to doctors and patients to better understand their problems and their needs.
For more disease state research, view the Market Insights Program.
Related
AMCP supports the Ensuring Community Access to Pharmacist Services Act. This bill will help ensure that Americans can continue to rely on pharmacists as essential partners in pandemic preparedness and response. The ECAPS Act will also improve patient access to tests and treatments by authorizing pharmacists to provide these services and receive reimbursement under Medicare Part B. The ECAPS Act addresses disparities in public health preparedness in medically underserved communities like rural areas by allowing these patients to seek care from their most accessible provider.
AMCP supports the Access to Prescription Digital Therapeutics Act. Expanding coverage of PDTs will improve care for millions of American patients and help standardize reimbursement practices and coding of these therapies across both public and private payers.
Featured News & Resources
See Full Calendar
National Meetings
Midwest AMCP Chicago Day of Education
National Meetings
Mountain West Pharmacy Summit
Upcoming Events
AMCP offers a wide variety of educational opportunities, from events and webinars to online training.
